Association of the diabetes gene calpain-10 with subclinical atherosclerosis: The Mexican-American coronary artery disease study

Diabetes

Volumn 54, Issue 4, 2005, Pages 1228-1232

  Goodarzi, Mark O ^a   Taylor, Kent D ^a   Guo, Xiuqing ^a   Quiñones, Manuel J ^b   Cui, Jinrui ^a   Li, Yanjie ^c   Saad, Mohammad F ^b   Yang, Huiying ^a   Hsueh, Willa A ^b   Hodis, Howard N ^c   Rotter, Jerome I ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CYSTEINE PROTEINASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CAPN10 GENE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COVARIANCE; FEMALE; GENE; GENETIC PREDISPOSITION; GLUCOSE CLAMP TECHNIQUE; HAPLOTYPE; HISPANIC; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ARTERIOSCLEROSIS; CALPAIN; CAROTID ARTERY DISEASES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MALE; MEXICAN AMERICANS; MIDDLE AGED; PHENOTYPE; TUNICA INTIMA;

EID: 20144389857     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.4.1228     Document Type: Article

References (25)

1. Motulsky AG, Brunzell JD: Genetics of coronary atherosclerosis. In The Genetic Basis of Common Diseases. 2nd ed. King RA, Rotter JI, Motulsky AG, Eds. New York, Oxford University Press, 2002, p. 105-126
2. Mitchell BD, Imumorin IG: Genetic determinants of diabetes and atherosclerosis. Curr Atheroscler Rep 4:193-198, 2002
3. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Kara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175, 2000
4. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, Ramachandran A, Snehalatha C, Gelding SV, Vijayaravaghan S, Curtis D, Hitman GA: Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51:1622-1628, 2002
5. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, Turnbull DM, Horikawa Y, Cox NJ, Bell GI, Walker M: Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51:247-250, 2002
6. Tschoepe D, Menart B, Ferber P, Altmann C, Haude M, Haastert B, Roesen P: Genetic variation of the platelet-surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with type 2 diabetes mellitus. Diabetologia 46:984-989, 2003
7. Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, Kawamoto T, Matsumoto S, Nagaretani H, Kumada M, Okamoto Y, Nishizawa H, Kishida K, Maeda N, Hiraoka H, Iwashima Y, Ishikawa K, Ohishi M, Katsuya T, Rakugi H, Ogihara T, Matsuzawa Y: Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 43:1195-1200, 2004
8. Marz W, Nauck M, Hoffmann MM, Nagel D, Boehm BO, Koenig W, Rothenbacher D, Winkelmann BR: G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. Circulation 109: 2844-2849, 2004
9. Benes P, Kankova K, Muzik J, Groch L, Benedik J, Elbl L, Izakovicova-Holla L, Vasku A, Znojil V, Vacha J: Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population. Mol Genet Metab 73:188-195, 2001
10. Goodarzi MO, Quo X, Taylor KD, Quinones MJ, Saad MF, Yang H, Hsueh WA, Rotter JI: Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes 53:214-220, 2004
11. Goodarzi MO, Quo X, Taylor KD, Quiñones MJ, Samayoa C, Yang H, Saad MF, Palotie A, Krauss RM, Hsueh WA, Rotter JI: Determination and use of haplotypes: ethnie comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med 5:322-327, 2003
12. Stalker TJ, Skvarka CB, Scalia R: A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J 17:1511-1513, 2003
13. Paulhe F, Bogyo A, Chap H, Perret B, Racaud-Sultan C: Vascular smooth muscle cell spreading onto fibrinogen is regulated by calpains and phospholipase C. Biochem Biophys Res Commun 288:875-881, 2001
14. Croce K, Flaumenhaft R, Rivers M, Furie B, Furie BC, Herman IM, Potter DA: Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J Biol Chem 274:36321-36327, 1999
15. Paul DS, Harmon AW, Winston CP, Patel YM: Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J 376:625-632, 2003
16. Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, Pan CY, Lee JP, Ostrega DM, Pugh W, Horikawa Y, Cox NJ, Hanis CL, Burant CF, Fox AP, Bell GI, Polonsky KS: Calpains play a role in insulin secretion and action. Diabetes 50:2013-2020, 2001
17. Zhou YP, Sreenan S, Pan CY, Currie KP, Bindokas VP, Horikawa Y, Lee JP, Ostrega D, Ahmed N, Baldwin AC, Cox NJ, Fox AP, Miller RJ, Bell GI, Polonsky KS: A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52:528-534, 2003
18. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, Silander K, Valle TT, Buchanan TA, Tuomilehto J, Bergman RN, Boehnke M, Collins FS: Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51:1644-1648, 2002
19. Livak KJ: Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149, 1999
20. Selzer RH, Mack WJ, Lee PL, Kwong-Fu H, Hodis HN: Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis 154:185-193, 2001
21. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
22. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC: Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190-198, 2000
23. Bergman RN, Ader M, Huecking K, Van Citters G: Accurate assessment of β-cell function: the hyperbolic correction. Diabetes 51 (Suppl. 1):S212-S220, 2002
24. Sobel E, Lange K: Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 58:1323-1337, 1996
25. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986